EIFO
EIFO is a government. It joined 3 rounds tracked by OSH in the last 90 days.
What they look for
Based on deals tracked by OSH, EIFO participates in growth-stage and later financing rounds across diversified sectors, backing companies without routinely acting as lead investor.
- Growth
- Usually participates
Activity
3
3
0
$62.6M
Frequent co-investors:Chr. Augustinus FabrikkerNordea-fondenATPIDAChristian Lund
Portfolio from OSH Rounds
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| €56M | Seed | — | Chr. Augustinus Fabrikker +9 | — | 1 | ||
| €4M | Undisclosed stage | Vitamin°C | Climentum Capital +1 | — | 1 | ||
| €67.5M | Series A | Mission BioCapital, Novo Holdings | Sound Bioventures +6 | — | 1 |
- PSV Tech€56M
with Chr. Augustinus Fabrikker, +9
Led by Vitamin°C · with Climentum Capital, +1
- Breye Therapeutics€67.5M
Led by Mission BioCapital, Novo Holdings · with Sound Bioventures, +6
Questions and answers
What stages does EIFO invest in?
EIFO invests at Growth (derived by OSH from its deals).
How active is EIFO?
In OSH Rounds, EIFO joined 3 rounds in the last 90 days and 3 in the last 12 months, leading 0.
Does EIFO lead rounds?
EIFO usually participates rather than leads.
Sources
- 1.Building on Fund I’s success, PSV Tech closes Fund II at €56 million with 19 investments already made — EU-Startups, Oct 8, 2026
- 2.FashionTech startup Rodinia Generation aims to save 100 billion litres of water annually, secures €4 million — EU-Startups, Oct 5, 2026
- 3.Denmark’s Breye Therapeutics raises €67.5 million to advance oral therapies for early treatment of retinal diseases — EU-Startups, Oct 2, 2026
- 4.OSH Investors — OSH Investors